Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

1. Molecular epidemiology of influenza A/H3N2 viruses circulating in Mexico from 2003 to 2012.PloS one · 2014
   Article
2. The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.Chemical reviews · 2013
   Review
3. Structural basis for proton conduction and inhibition by the influenza M2 protein.Protein science : a publication of the Protein Society · 2012
   Review
4. Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic.Clinical microbiology reviews · 2012
   Review
5. Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus.Current opinion in structural biology · 2011
   Review
6. Genomic signature-based identification of influenza A viruses using RT-PCR/electro-spray ionization mass spectrometry (ESI-MS) technology.PloS one · 2010
   Article
7. Occurrence of mixed populations of influenza A viruses that can be maintained through transmission in a single host and potential for reassortment.Journal of clinical microbiology · 2010
   Article
8. Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008).The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2010
   Article
9. Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008.Influenza and other respiratory viruses · 2009
   Article
10. Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.Antimicrobial agents and chemotherapy · 2009
    Article
11. The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.Virology · 2009
    Article
12. Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis.Virology journal · 2009
    Article
13. Structural basis for the function and inhibition of an influenza virus proton channel.Nature · 2008
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as